HRT in difficult circumstances: are there any absolute contraindications?

Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear?

(2013) Sengwee Toh   ANNALS OF INTERNAL MEDICINE

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

(2010) Richard J. Santen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hormone Replacement Therapy, Family History, and Breast Cancer Risk Among Postmenopausal Women

(2009) Robert Gramling et al.   EPIDEMIOLOGY

Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial

(2009) Patrice Boyer et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well

(2009) Heli K. Lyytinen et al.   INTERNATIONAL JOURNAL OF CANCER

Hormone Therapy and Ovarian Cancer

(2009) Lina Steinrud Mørch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

(2009) Peter Kenemans et al.   LANCET ONCOLOGY

Hormone replacement after gynaecological cancer

(2009) Piksi Singh et al.   MATURITAS

Gabapentin for the treatment of menopausal hot flashes

(2009) Debra A. Butt et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

(2008) Michael R. Liebowitz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Hormone replacement therapy and ovarian cancer risk: A meta-analysis

(2008) Bo Zhou et al.   GYNECOLOGIC ONCOLOGY

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

(2008) A. Eisen et al.   JNCI-Journal of the National Cancer Institute

Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors

(2008) L. Holmberg et al.   JNCI-Journal of the National Cancer Institute

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of the levonorgestrel-releasing intrauterine system in breast cancer patients

(2007) Xuan Bich Trinh et al.   FERTILITY AND STERILITY